Lihteh Wu

Twelve-month safety of intravitreal injections of bevacizumab (Avastin®): results of the Pan-American Collaborative Retina Study Group (PACORES)

Lihteh Wu, María Ana Martinez-Castellanos, Hugo Quiroz–Mercado et al. · Graefe s Archive for Clinical and Experimental Ophthalmology · 2007 · 454 citations

Ocular Disease, Vitreous Body, Experimental Ophthalmology +4

Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy

J. Fernando Arévalo, Maurício Maia, Harry W. Flynn et al. · British Journal of Ophthalmology · 2007 · 404 citations

Primary Intravitreal Bevacizumab (Avastin) for Diabetic Macular Edema

J. Fernando Arévalo, Jans Fromow-Guerra, Hugo Quiroz–Mercado et al. · Ophthalmology · 2007 · 335 citations · Full text

Diabetic Retinopathy, Ocular Disease, Ophthalmology +3

Primary Intravitreal Bevacizumab for Diffuse Diabetic Macular Edema

J. Fernando Arévalo, J. García Sánchez, Lihteh Wu et al. · Ophthalmology · 2009 · 125 citations · Full text

Diabetic Retinopathy, Ocular Disease, Vitreous Body +5

Intravitreal bevacizumab (avastin) for proliferative diabetic retinopathy: 6-months follow-up

J. Fernando Arévalo, Lihteh Wu, J. García Sánchez et al. · Eye · 2007 · 123 citations · Full text

Diabetic Retinopathy, Ocular Disease, Vitreous Body +4